These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 2903628)

  • 1. Liver involvement in human schistosomiasis mansoni. Regression of immunological and biochemical disease markers after specific treatment.
    Zwingenberger K; Harms G; Feldmeier H; Müller O; Steiner A; Bienzle U
    Acta Trop; 1988 Sep; 45(3):263-75. PubMed ID: 2903628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver involvement in human schistosomiasis mansoni. Assessment by immunological and biochemical markers.
    Zwingenberger K; Feldmeier H; Queiroz JA; Siqueira JG; Auto HF; Alencar JE; Bienzle U
    Parasitol Res; 1988; 74(5):448-55. PubMed ID: 3137558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Praziquantel in the treatment of hepatosplenic schistosomiasis: biochemical disease markers indicate deceleration of fibrogenesis and diminution of portal flow obstruction.
    Zwingenberger K; Richter J; Vergetti JG; Feldmeier H
    Trans R Soc Trop Med Hyg; 1990; 84(2):252-6. PubMed ID: 2117787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Re-infection in human schistosomiasis mansoni: a prospective field study 18 months after praziquantel therapy.
    Zwingenberger K; Harms G; Poggensee U; Steiner A; Müller O; Feldmeier H
    Ann Trop Med Parasitol; 1990 Oct; 84(5):457-65. PubMed ID: 2124097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology, immunology and chemotherapy of Schistosoma mansoni infections in a recently exposed community in Senegal.
    Gryseels B; Stelma FF; Talla I; van Dam GJ; Polman K; Sow S; Diaw M; Sturrock RF; Doehring-Schwerdtfeger E; Kardorff R
    Trop Geogr Med; 1994; 46(4 Spec No):209-19. PubMed ID: 7825223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of early treatment with praziquantel on serum connective tissue metabolite markers in children and adolescents with intestinal schistosomiasis mansoni.
    Hassanein HI; Zoheiry MM; Voss B; el Attar GM; Hassan SI; Demerdash ZA; el Baz HM; Yousif OA
    Arzneimittelforschung; 1997 Jan; 47(1):84-7. PubMed ID: 9037450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune responses during human schistosomiasis. XII. Differential responsiveness in patients with hepatosplenic disease.
    Colley DG; Garcia AA; Lambertucci JR; Parra JC; Katz N; Rocha RS; Gazzinelli G
    Am J Trop Med Hyg; 1986 Jul; 35(4):793-802. PubMed ID: 3089040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intranasal administration of a Schistosoma mansoni glutathione S-transferase-cholera toxoid conjugate vaccine evokes antiparasitic and antipathological immunity in mice.
    Sun JB; Mielcarek N; Lakew M; Grzych JM; Capron A; Holmgren J; Czerkinsky C
    J Immunol; 1999 Jul; 163(2):1045-52. PubMed ID: 10395703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevation of laminin and beta-subunit of prolyl 4-hydroxylase in the sera of human subjects with Schistosomiasis mansoni.
    Tanabe M; Sekiguchi T; Kaneko N; Kobayashi S; Takeuchi T; Coutinho A; Tateno S; Maruyama K; Okazaki I
    Jpn J Exp Med; 1989 Jun; 59(3):109-19. PubMed ID: 2554032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of Schistosoma mansoni infection increases helminth-specific type 2 cytokine responses and HIV-1 loads in coinfected Ugandan adults.
    Brown M; Mawa PA; Joseph S; Bukusuba J; Watera C; Whitworth JA; Dunne DW; Elliott AM
    J Infect Dis; 2005 May; 191(10):1648-57. PubMed ID: 15838791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Some immunological aspects on human Schistosoma mansoni infection in Egypt.
    el Marsafy A; el Okbi SM; el Adawy N
    J Egypt Soc Parasitol; 1993 Apr; 23(1):179-87. PubMed ID: 8482864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of single-dose praziquantel on morbidity and mortality resulting from intestinal schistosomiasis.
    Kheir MM; Baraka OZ; el-Tom IA; Mukhtar MM; Homieda MM
    East Mediterr Health J; 2000; 6(5-6):926-31. PubMed ID: 12197350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequency of schistosomiasis mansoni, of its clinicopathological forms and of the ectopic locations of the parasite in autopsies in Belo Horizonte, Brazil.
    Gonçalves EC; Fonseca AP; Pittella JE
    J Trop Med Hyg; 1995 Oct; 98(5):289-95. PubMed ID: 7563253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of Schistosoma mansoni induced intestinal inflammation by means of eosinophil cationic protein, eosinophil protein X and myeloperoxidase before and after treatment with praziquantel.
    Reimert CM; Tukahebwa EM; Kabatereine NB; Dunne DW; Vennervald BJ
    Acta Trop; 2008 Mar; 105(3):253-9. PubMed ID: 18177822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversibility of Schistosoma mansoni-associated morbidity after yearly mass praziquantel therapy: ultrasonographic assessment.
    Boisier P; Ramarokoto CE; Ravaoalimalala VE; Rabarijaona L; Serieye J; Roux J; Esterre P
    Trans R Soc Trop Med Hyg; 1998; 92(4):451-3. PubMed ID: 9850407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasoactive intestinal peptide inhibits liver pathology in acute murine schistosomiasis mansoni and modulates IL-10, IL-12 and TNF-alpha production.
    Allam G
    Immunobiology; 2007; 212(8):603-12. PubMed ID: 17869638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell mediated immune (CMI) responsiveness to soluble egg antigen (SEA) and its relation to the occurrence of schistosomal hepatosplenic disease in patients with schistosomiasis mansoni.
    Helmy-Khalil S; Fahmy MH; Ghanem MH; Said M; El Sawy M; Nofal M; Awadalla HN; Youssef M; Mucke D; Brock J
    Tropenmed Parasitol; 1979 Dec; 30(4):426-8. PubMed ID: 538816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunomodulatory effects of curcumin treatment on murine schistosomiasis mansoni.
    Allam G
    Immunobiology; 2009; 214(8):712-27. PubMed ID: 19249123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations between specific antibody responses and resistance to reinfection in a Senegalese population recently exposed to Schistosoma mansoni.
    Vereecken K; Naus CW; Polman K; Scott JT; Diop M; Gryseels B; Kestens L
    Trop Med Int Health; 2007 Mar; 12(3):431-44. PubMed ID: 17313515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction in prevalence, intensity of infection and morbidity due to Schistosoma mansoni infection in a community following treatment with praziquantel.
    Sukwa TY; Bulsara MK; Wurapa FK
    J Trop Med Hyg; 1987 Aug; 90(4):205-11. PubMed ID: 3116277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.